The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADVERUM BIOTECHNOLOGIES INC COM 00773U108 808 74,530 SH   SOLE   0 0 74,530
INTUIT COM 461202103 769 2,025 SH   SOLE   0 0 2,025
JBG SMITH COM COM 46590V100 55,029 1,759,817 SH   SOLE   0 0 1,759,817
OCULAR THERAPEUTIX INC COM 67576A100 629 30,410 SH   SOLE   0 0 30,410
TRANSDIGM GROUP INC COM 893641100 9,658 15,607 SH   SOLE   0 0 15,607